Roche Holding AG Share Price Swiss Exchange
Stocks
RO
CH0012032113
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Swiss Exchange
16:31:55 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 405.40 CHF | +0.50% |
|
+2.48% | +20.94% |
| 06:41am | DKSH Secures Rights for Roche's Antibiotic Brand Rocephin in Over 80 Markets | MT |
| 10-27 | Roche's New Immunoassay Testing Platform Receives CE Mark | MT |
| Market Cap | 319B 384B 345B 289B 540B 36,516B 547B 3,820B 1,517B 19,140B 1,443B 1,412B 60,697B | P/E 2026 * |
21.5x | P/E 2027 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise Value | 330B 398B 357B 299B 559B 37,820B 566B 3,956B 1,571B 19,824B 1,495B 1,463B 62,864B | EV / Sales 2026 * |
5.22x | EV / Sales 2027 * | 4.88x |
| Free-Float |
88.78% | Yield 2026 * |
2.51% | Yield 2027 * | 2.58% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| RO | Delayed | |
CBOE
| 0QQ6 | Real-time | |
|
Xetra
| RHO | End-of-day quote | |
|
Tradegate
| RHO | Real-time | |
|
Xetra
| RHO | Delayed | |
|
London S.E.
| 0QQ6 | Delayed | |
|
Deutsche Boerse AG
| RHO | Delayed | |
|
OTC Markets
| RHHBF | Delayed | |
|
Börse Stuttgart
| RHO | Delayed | |
|
Boerse Muenchen
| RHO | Real-time | |
|
Borsa Italiana
| 1RO | End-of-day quote | |
|
Wiener Boerse
| ROGH | End-of-day quote |
Last Transcript: Roche Holding AG
| 1 day | +0.50% | ||
| 1 week | +2.48% | ||
| Current month | +12.36% | ||
| 1 month | +8.05% | ||
| 3 months | +11.07% | ||
| 6 months | +22.85% | ||
| Current year | +20.94% |
| 1 week | 392.2 |  | 406 |
| 1 month | 353.8 | | 406 |
| Current year | 301.2 | | 406 |
| 1 year | 270.8 | | 406 |
| 3 years | 229.4 | | 406 |
| 5 years | 229.4 | | 439.2 |
| 10 years | 209.4 | | 439.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 14/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 05/06/2011 |
| Chief Operating Officer | - | 30/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 31/12/1995 |
Severin Schwan
CHM | Chairman | 59 | 14/03/2023 |
| Director/Board Member | 73 | 02/03/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.50% | +2.48% | - | - | 384B | |
| +0.22% | -0.14% | +55.12% | +128.82% | 1,143B | |
| +0.91% | +3.61% | +41.21% | +84.57% | 647B | |
| -0.12% | -0.93% | +25.59% | +106.14% | 506B | |
| +0.63% | +2.33% | +49.21% | +67.82% | 384B | |
| +0.86% | -4.37% | +61.16% | +37.93% | 350B | |
| +1.02% | +1.80% | +24.84% | +53.75% | 293B | |
| -0.25% | +1.62% | +2.20% | +26.65% | 265B | |
| +0.75% | +2.05% | +53.85% | +71.25% | 242B | |
| +0.25% | +1.64% | +32.05% | +107.62% | 197B | |
| Average | +0.48% | +0.85% | +38.36% | +76.06% | 447.5B | |
| Weighted average by Cap. | +0.45% | +0.71% | +42.25% | +88.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.26B 76.34B 68.51B 57.37B 107B 7,251B 109B 758B 301B 3,801B 287B 280B 12,052B | 66.14B 79.82B 71.64B 59.98B 112B 7,581B 113B 793B 315B 3,974B 300B 293B 12,602B |
| Net income | 14.82B 17.89B 16.05B 13.44B 25.12B 1,699B 25.43B 178B 70.58B 891B 67.15B 65.71B 2,824B | 16.58B 20B 17.95B 15.03B 28.09B 1,900B 28.44B 199B 78.92B 996B 75.08B 73.47B 3,158B |
| Net Debt | 11.37B 13.72B 12.32B 10.31B 19.28B 1,304B 19.51B 136B 54.15B 683B 51.52B 50.41B 2,167B | 4.46B 5.38B 4.83B 4.04B 7.56B 511B 7.65B 53.46B 21.23B 268B 20.2B 19.76B 849B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/10/26 | CHF 405.40 | +0.50% | 27,431 |
| 26/10/26 | CHF 403.40 | +1.51% | 25,189 |
| 23/10/26 | CHF 397.40 | -0.15% | 25,455 |
| 22/10/26 | CHF 398.00 | +0.20% | 27,854 |
| 21/10/26 | CHF 397.20 | +0.40% | 29,275 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- RO Stock
Select your edition
All financial news and data tailored to specific country editions
